Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with ...

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell ...
New Scientist

Our bodies are ageing faster than ever. Can we hit the brakes?

All over the world people are ageing more rapidly and succumbing to diseases that typically affected the elderly. But there are ways to turn back the clock on your biological age ...